Is vaping really that safe?

More research is urgently needed on the electronic cigarette. Electronic cigarettes have come on the market as an aid to quit smoking common tobacco products. They are presented as safe alternatives because they do not burn anything and therefore no toxic combustion products such as tar can form. But that wasn’t preceded by toxicology testing or long-term safety testing in humans. However, they are required for all other conventional treatments and medical devices.

Whether they are a good way to renounce the regular cigarette is in itself up for debate. But it is also far from clear whether electronic cigarettes are less harmful than regular tobacco products. Because whether they increase the risk of lung diseases such as lung cancer and COPD may not be clear until the middle of this century, when the electronic cigarette has been used for decades.

An electronic cigarette heats and vaporizes a mixture of glycerine, propylene glycol, nicotine and flavorings that you inhale into the lungs. It emits volatile carbonyls, reactive oxygen species, furans and metals such as nickel, lead and chromium, most of which are harmful to the lungs.

E-cigarettes are mainly used by ex-smokers, which complicates research

American scientists led by Robert Tarran of the University of North Carolina examined more than 5,000 studies on the electronic cigarette that appeared between 1980 and the end of June 2019. They found evidence that e-cigarette use increases the risk of symptoms of respiratory diseases such as chronic coughing, mucus formation and bronchitis. Check Mr-joy.co.uk e liquid store for more information. And that vaping can have a negative effect on the cells and physiology of the lungs and of the immune system. In addition, e-cigarettes are almost exclusively used by ex-smokers, which complicates the research.

According to the researchers, it is impossible to estimate whether or not electronic cigarettes are healthier than other tobacco products, because long-term toxicology or safety studies in humans have not yet been conducted. They argue that the devices should be subject to the same rules as are all other pharmaceutical products.